TheraRadar
← Back
Data updated: Jul 17, 2026

EPI HLTH

Pharma
Pharmaceuticals

EPI HLTH is a pharmaceutical company with 1 FDA-approved products.

2017
Since
1
Drugs
-
Trials
0
New Drugs (2yr)

EPI HLTH's Key Drugs

EPI HLTH's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).

No active drugs

EPI HLTH's Recent FDA Approvals

New NDA/BLA approvals for EPI HLTH over the last two years — novel drugs only, excluding generics and label supplements.

No recent approvals

EPI HLTH's Therapeutic Areas

Disease areas where EPI HLTH has approved drugs and an active pipeline. Weighted by commercial stage — approved drugs count most, then late-stage trials.

No indication data

EPI HLTH Pipeline Snapshot

Active clinical trials for EPI HLTH across all therapeutic areas, from ClinicalTrials.gov.

No active pipeline data available

Pro Intelligence Preview

Deep insights for investors and analysts

Revenue Insights

  • • Top drug revenue breakdown
  • • Drug-level revenue analysis

Trial Catalysts

  • • Active trial monitoring
  • • Phase 3 readout tracking

Patent Risk

  • • Patent expiration timeline
  • • Revenue at risk analysis

Compare Companies

  • • Side-by-side pipeline analysis
  • • Revenue & market share comparison
Unlock Full Intelligence

Revenue forecasts • Trial milestones • Patent risk modeling